Loss of STIM1 and STIM2 in salivary glands disrupts ANO1 function but does not induce Sjogren's disease
Sjogrens disease (SjD) is an autoimmune disease characterized by xerostomia (dry mouth),
lymphocytic infiltration into salivary glands and the presence of SSA and SSB …
lymphocytic infiltration into salivary glands and the presence of SSA and SSB …
New‐onset primary Sjögren's syndrome following exposure to severe acute respiratory syndrome coronavirus 2: A retrospective cohort study
S Liu, J Zhang, M Liu, Q Chen, S Wang… - Rheumatology & …, 2024 - mednexus.org
Background Understanding the clinical implications of autoimmune manifestations
associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is …
associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is …
Fieber bei rheumatologischen Erkrankungen
JF Nies, M Krusche - Zeitschrift für Rheumatologie, 2024 - Springer
Fieber bei PatientInnen mit rheumatologischen Erkrankungen ist ein häufiges und wichtiges
Symptom, das durch die Aktivität der rheumatologischen Grunderkrankung bedingt sein …
Symptom, das durch die Aktivität der rheumatologischen Grunderkrankung bedingt sein …
[PDF][PDF] Sjogren's Antibodies and Neonatal Lupus: A Scoping Review
D Nagliya, C Castellano, ML Demory, MM Kesselman… - Cureus, 2024 - cureus.com
Sjogren's syndrome (SS) is an autoimmune disease characterized by inflammation of
exocrine glands. The disorder predominantly affects middle-aged women. Autoantibodies …
exocrine glands. The disorder predominantly affects middle-aged women. Autoantibodies …
[HTML][HTML] Severe headache in primary Sjögren's syndrome responded to rituximab
Discussion Headache that may presented in pSS are tension headaches, migraines and
cluster headaches. The therapy is disease-modifying antirheumatic drugs …
cluster headaches. The therapy is disease-modifying antirheumatic drugs …
POS1243 ASSOCIATION OF SJÖGREN'S DISEASE ACTIVITY (ClinESSDAI) AND SYMPTOM BURDEN (ESSPRI) WITH PATIENT-REPORTED OUTCOME …
JE Gottenberg, N Massey, M Hughes, V Barton… - 2024 - ard.bmj.com
Background: Clinical EULAR Sjögren's syndrome disease activity index (clinESSDAI) and
EULAR Sjögren's syndrome patient-reported index (ESSPRI) are commonly utilized clinical …
EULAR Sjögren's syndrome patient-reported index (ESSPRI) are commonly utilized clinical …
Animal models of Dry Eye Disease: Application to Drug Discovery
F Khwaja, RA Honkanen, B Rigas - Medical Research Archives, 2024 - esmed.org
Dry eye disease (DED), a multifactorial disorder of the ocular surface and tear film, affects 5-
50% of the global population. Currently, no satisfactory treatments of DED exist. Ongoing …
50% of the global population. Currently, no satisfactory treatments of DED exist. Ongoing …
Oral manifestations in different stages of chronic kidney disease
E Palmeira, S Egido-Moreno, C Omaña-Cepeda… - 2024 - researchsquare.com
Background Chronic kidney disease is a progressive, slow and silent disease characterized
by kidney damage and a consequent reduction of kidney function. The final stage indicates …
by kidney damage and a consequent reduction of kidney function. The final stage indicates …
POS1257 COMPARISON OF REGULATORY B CELLS IN PERIPHERAL BLOOD AND CLINICAL CHARACTERISTICS BETWEEN IGURATIMOD AND …
J Zou, L Yang, J Yang, J Luo, S LI, Y Zhang, J Dong… - 2024 - ard.bmj.com
Background: The pathogenesis of Primary Sjögren's syndrome (pSS) is complex and the
treatment is difficult, the enhanced activation of polyclonal B lymphocytes is the …
treatment is difficult, the enhanced activation of polyclonal B lymphocytes is the …
Caracterización clínica y epidemiológica del Síndrome de Sjögren.
TM Ambuludi Medina, ET Arévalo Mullo - 2024 - dspace.unach.edu.ec
El síndrome de Sjögren (SS) representa un intrigante desafío médico, siendo una afección
autoinmune multisistémica, la relevancia médica de esta enfermedad radica en su …
autoinmune multisistémica, la relevancia médica de esta enfermedad radica en su …